Market revenue in 2022 | USD 306.0 million |
Market revenue in 2030 | USD 3,452.9 million |
Growth rate | 35.4% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.5% in 2022. Horizon Databook has segmented the U.S. artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
The increasing demand for personalized treatment is the primary factor driving market expansion in the country. Furthermore, rising demand for reducing healthcare expenditure and growing patient health-related digital information datasets are fueling market growth.
The rising global geriatric population, changing lifestyle, and growing prevalence of chronic illnesses have increased the need for early disease diagnosis and treatment. Machine Learning (ML) and AI algorithms are widely adopted and incorporated into healthcare systems to reliably anticipate illnesses in their preliminary stages based on past health records.
For instance, as per a research study by the University of California, in September 2022, Irvine provides a unique treatment for Inherited Retinal Disorders (IRDs) by implementing precise genome editing, which is highly tailored to the needs of an individual.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. artificial intelligence in precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into U.S. artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account